Serious Event

Serious Event

Serious Adverse Events (SAEs) are adverse events that result in death, are life-threatening, require or prolong hospitalization, cause persistent or significant disability/incapacity, or are congenital anomalies/birth defects. Each serious event is categorized by term, organ system, assessment type, and source vocabulary to provide standardized reporting across clinical trials.

Serious Event path is as follows:

Study -> Results Section -> Adverse Events Module -> Serious Event

Study -> Results Section -> Adverse Events Module -> Serious Event -> Serious Event Stats

Serious Event


Ignite Creation Date: 2025-12-24 @ 7:32 PM
Ignite Modification Date: 2025-12-25 @ 5:14 PM
NCT ID: NCT01292603
Term: Brain Neoplasm
Organ System: Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Assessment Type: NON_SYSTEMATIC_ASSESSMENT
Source Vocabulary: MedDRA (20.1)
Notes: None
Study: NCT01292603
Study Brief: A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia
Serious Event Stats (If Any):

Serious Event Stats

Group ID # Events # Affected # At Risk View
EG000 None 1 16 View
EG002 None 0 22 View
EG003 None 0 1 View
EG004 None 0 8 View
EG005 None 0 89 View
EG001 None 0 17 View
EG006 None 0 85 View